by Sarah Stapleton | Aug 12, 2024
On August 9, 2024, Shanghai ChemPartner Co., Ltd (ChemPartner) and the Hong Kong Polytechnic University (PolyU) marked the signing of a Memorandum of Understanding (MOU). The MOU was signed by Professor Larry Ming Cheung Chow, Head of the Department of Applied Biology...
by Corah Whipple | Dec 22, 2023
Newly-launched database offers easier access to diverse tumor models and unveils the path to pharmaceutical breakthroughs ChemPartner, a global leader in drug discovery and development services, today announced the launch of its long-awaited Biology Database....
by Corah Whipple | Jun 21, 2023
ChemPartner announced today the appointment of Yinfei Yin, Ph.D. as vice president of and head of the biology and pharmacology department at Shanghai ChemPartner. Dr. Yin brings a wealth of experience and expertise to his new role, having established himself as a...
by Sarah Stapleton | Feb 6, 2023
ChemPartner received a 2023 CDMO Leadership Award in Every Core Category There are six core categories in the CDMO Leadership Awards: Capabilities, Compatibility, Expertise, Quality, Reliability and Service. Winners in these categories are judged by their...
by Sarah Stapleton | Mar 23, 2021
Shanghai, China (March 23, 2020) – Shanghai ChemPartner announced today the appointment of Cheng-Chi Chao, Ph.D. as Vice President and Head of Immunotherapy and Inflammation. Dr. Chao has over 20 years of experience in drug development and extensive expertise in the...
by Sarah Stapleton | Jun 11, 2020
Shanghai, China (June 9, 2020) – Shanghai ChemPartner announced the additional investments the company is making into its biologics business unit to further its capabilities and capacity in biologics discovery through development and manufacturing. “ChemPartner has...
by Sarah Stapleton | May 12, 2020
Shanghai, China (May 12, 2020) – Shanghai ChemPartner announced they have entered into a non-exclusive agreement with the Mount Sinai Health System (Mount Sinai) to assist in a trial production run of a component of the Mount Sinai COVID-19 serological assay that...
by Sarah Stapleton | Apr 17, 2020
SAN FRANCISCO, Calif. and SHANGHAI, China. (April 15, 2020) – In a new collaboration, Chempartner Corporation (ChemPartner), the US arm of a leading pre-clinical contract research and development organization (CRO), is partnering with scientists at Gladstone...
by Sarah Stapleton | Apr 2, 2020
Shanghai, China (March 17, 2020) – Shanghai ChemPartner announced the opening of a new, state-of-the-art, 24,000 m2 laboratory facility in the Zhangjiang Hi-Tech Park in Shanghai, China. The building, operating as ChemPartner’s new Global Operation Center, houses...
by Sarah Stapleton | Dec 18, 2019
Shanghai, China (December 17, 2019) – Shanghai ChemPartner announced the appointment of Jie Jack Li, Ph.D. as a Vice President of Discovery Chemistry at the Company headquarters in Shanghai, China. Dr. Li is an established chemist with over 20 years of experience in...
